We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type |
---|---|---|---|
Kelvin Medical Inc (CE) | USOTC:KVMD | OTCMarkets | Common Stock |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
0.00 | 0.00% | 0.0001 | 0.00 | 01:00:00 |
SEC FILE NUMBER:
|
333-212791
|
CUSIP NUMBER:
|
(
Check One
):
|
[X] Form 10-K
[ ] Form 20-F [ ] Form 11-K [] Form 10-Q [ ] Form 10-D [ ] Form N-SAR [ ] Form N-CSR
|
||
|
|||
|
For Period Ended:
|
June 30, 2017
|
|
|
|||
|
[ ] Transition Report on Form 10-K
|
|
|
|
[ ] Transition Report on Form 20-F
|
|
|
|
[ ] Transition Report on Form 11-K
|
|
|
|
[ ] Transition Report on Form 10-Q
|
|
|
|
[ ] Transition Report on Form N-SAR
|
|
|
|
|||
|
For the Transition Period Ended:
|
|
|
If the notification relates to a portion of the filing checked above, identify the Item(s) to which the notification relates:
|
|
Nothing in this form shall be construed to imply that the Commission has verified any information contained herein.
|
PART I - REGISTRANT INFORMATION
|
|
Full Name of Registrant
|
|
|
Former Name if Applicable
|
|
10930 Skyranch Place
|
Address of Principal Executive Office (Street and Number)
|
|
Nevada City, CA 95959
|
City, State and Zip Code
|
PART II – RULES 12b-25(b) AND (c)
|
|||
|
|||
If the subject report could not be filed without unreasonable effort or expense and the registrant seeks relief pursuant to Rule 12b-25(b), the following should be completed. (Check box if appropriate)
|
|||
|
|||
|
[
X
]
|
(a)
|
The reason described in reasonable detail in Part III of this form could not be eliminated without unreasonable effort or expense.
|
|
[
X
]
|
(b)
|
The subject annual report, semi-annual report, transition report on Form 10-K, Form 20-F, 11-K, Form N-SAR or Form N-CSR, or portion thereof, will be filed on or before the fifteenth calendar day following the prescribed due date; or the subject quarterly report of transition report on Form 10-Q or subject distribution report on Form 10-D, or portion thereof, will be filed on or before the fifth calendar day following the prescribed due date; and
|
|
|
(c)
|
The accountant's statement or other exhibit required by Rule 12b-25(c) has been attached if applicable.
|
PART III – NARRATIVE
|
|
State below in reasonable detail why Forms 10-K, 20-F, 11-K, 10-Q, 10-D, N-SAR, N-CSR, or the transition report or portion thereof, could not be filed within the prescribed time period.
|
|
The Form 10-K for the year ended June 30, 2017 will not be submitted by the deadline due to a situation where the workload exceeds available personnel. We were not able to complete all of the financial information required to allow sufficient time for our independent auditors to be able to finalize their review and provide their consent by the filing deadline of September 28, 2017.
|
PART IV – OTHER INFORMATION
|
||||||
|
||||||
(1)
|
Name and telephone number of person to contact in regard to this notification
|
|||||
|
||||||
|
William Mandel
|
|
530
|
|
388-8706
|
|
|
(Name)
|
|
(Area Code)
|
|
(Telephone Number)
|
|
|
||||||
(2)
|
Have all other periodic reports required under Section 13 or 15(d) of the Securities Exchange Act of 1934 or Section 30 of the Investment Company Act of 1940 during the preceding 12 months or for such shorter period that the registrant was required to file such report(s) been filed? If answer is no, identify report(s).
|
|||||
|
||||||
|
Yes [X] No [ ]
|
|
||||
|
|
|
|
KELVIN MEDICAL, INC
|
|
||||
|
Name of Registrant as Specified in Charter
|
|
||||
|
||||||
has caused this notification to be signed on its behalf by the undersigned hereunto duly authorized.
|
||||||
|
||||||
|
||||||
Date:
|
September 28, 2017
|
|
By:
|
/s/
William Mandel
|
||
|
|
|
Name:
|
William Mandel
|
||
|
|
|
Title:
|
President, Chief Executive Officer, Chief Financial Officer, Secretary, Treasurer & Director
|
ATTENTION
|
Intentional misstatements or omissions of fact constitute Federal Criminal Violations (See 18 U.S.C. 1001).
|
1 Year Kelvin Medical (CE) Chart |
1 Month Kelvin Medical (CE) Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions